参考文献/References:
[1] Kleinberger JW,Pollin TI.Undiagnosed MODY:time for action[J]. Curr Diab Rep,2015,15(12):110. DOI:10.1007/s11892-015-0681-7.
[2] 中华医学会糖尿病学分会胰岛素抵抗学组(筹).胰岛素抵抗评估方法和应用的专家指导意见[J].中华糖尿病杂志,2018,10(6):377-385.DOI:10.3760/cma.j.issn.1674-5809.2018.06.001.
[3] Deng M,Xiao X,Zhou L,et al.First case report of maturity-onset diabetes of the young type 4 pedigree in a Chinese family[J].Front Endocrinol(Lausanne),2019,10:406.DOI:10.3389/fendo.2019.00406.
[4] 范馨月,张萍,张霞.PDX-1基因突变所致MODY4的1例病例报告及文献复习[J].国际内分泌代谢杂志,2020,40(5):355-356,360.DOI:10.3760/cma.j.cn121383-20191223-12068.
[5] Caetano LA,Santana LS,Costa-Riquetto AD,et al.PDX1-MODY and dorsal pancreatic agenesis:new phenotype of a rare disease[J].Clin Genet,2018,93(2):382-386.DOI:10.1111/cge.13044.
[6] Chapla A,Mruthyunjaya MD,Asha HS,et al.Maturity onset diabetes of the young in India-a distinctive mutation pattern identified through targeted next-generation sequencing[J].Clin Endocrinol(Oxf),2015,82(4):533-542.DOI:10.1111/cen.12541.
[7] Cockburn BN,Bermano G,Boodram LL,et al.Insulin promoter factor-1 mutations and diabetes in Trinidad:identification of a novel diabetes-associated mutation(E224K)in an Indo-Trinidadian family[J].J Clin Endocrinol Metabol,2004,89(2):971-978.DOI:10.1210/jc.2003-031282.
[8] Fajans SS,Bell GI,Paz VP,et al.Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60[J].Transl Res,2010,156(1):7-14.DOI:10.1016/j.trsl.2010.03.003.
[9] Gragnoli C,Stanojevic V,Gorini A,et al.IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes[J].Metabolism,2005,54(8):983-988.DOI:10.1016/j.metabol.2005.01.037.
[10] Mangrum C,Rush E,Shivaswamy V.Genetically targeted dipeptidyl peptidase-4 inhibitor use in a patient with a novel mutation of MODY type 4[J].Clin Med Insights Endocrinol Diabetes,2015,8:83-86.DOI:10.4137/CMED.S31926.
[11] Mohan V,Radha V,Nguyen TT,et al.Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young(MODY)patients in South India[J].BMC Med Genet,2018,19(1):22.DOI:10.1186/s12881-018-0528-6.
[12] Fajans SS,Bell GI,Paz VP,et al.Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60[J].Transl Res,2010,156(1):7-14.DOI:10.1016/j.trsl.2010.03.003.
[13] Weng J,Macfarlane WM,Lehto M,et al.Functional consequences of mutations in the MODY4 gene(IPF1)and coexistence with MODY3 mutations[J].Diabetologia,2001,44(2):249-258.DOI:10.1007/s001250051608.
[14] Agˇladorˇlu SY,Aycan Z,Çetinkaya S,et al.Maturity onset diabetes of youth(MODY)in Turkish children:sequence analysis of 11 causative genes by next generation sequencing[J].J Pediatr Endocrinol Metab,2016,29(4):487-496.DOI:10.1515/ jpem-2015-0039.
[15] Aarthy R,Aston-Mourney K,Mikocka-Walus A,et al.Clinical features,complications and treatment of rarer forms of maturity-onset diabetes of the young(MODY)-a review[J].J Diabetes Complications,2021,35(1):107640.DOI:10.1016/j.jdiacomp.2020.107640.
[16] Kaneto H,Matsuoka TA,Miyatsuka T,et al.PDX-1 functions as a master factor in the pancreas[J].Front Biosci,2008,13:6406-6420.DOI:10.2741/3162.
[17] Tattersall RB,Fajans SS.A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people[J].Diabetes,1975,24(1):44-53.DOI:10.2337/diab.24.1.44.
[18] Zhu Y,Liu Q,Zhou Z,et al.PDX1,neurogenin-3,and MAFA:critical transcription regulators for beta cell development and regeneration[J].Stem Cell Res Ther,2017,8(1):240.DOI:10.1186/s13287-017-0694-z.
[19] Trojanowski BM,Salem HH,Neubaue H,et al.Elevated β-cell stress levels promote severe diabetes development in mice with MODY4[J].J Endocrinol,2020,244(2):323-337.DOI:10.1530/JOE-19-0208.
[20] Edfalk S,Steneberg P,Edlund H.Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion[J].Diabetes,2008,57(9):2280-2287.DOI:10.2337/db08-0307.
[21] Mangrum C,Rush E,Shivaswamy V.Genetically targeted dipeptidyl peptidase-4 inhibitor use in a patient with a novel mutation of MODY type 4[J].Clin Med Insights Endocrinol Diabetes,2015,8:83-86.DOI:10.4137/CMED.S31926.
[22] Li XJ,Mao XD,Chen GF,et al.High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules[J].Medicine(Baltimore),2019,98(28):e16343.DOI:10.1097/MD.0000000000016343.
[23] Schmid D,Behrens G,Jochem C,et al.Physical activity,diabetes,and risk of thyroid cancer:a systematic review and meta-analysis[J].Eur J Epidemiol,2013,28(12):945-958.DOI:10.1007/s10654-013-9865-0.
[24] Kang YY,Li JJ,Sun JX,et al.Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus[J].Clin Transl Oncol,2021,23(12):2536-2547.DOI:10.1007/s12094-021-02656-z.